Ticagrelor Versus Prasugrel in Diabetes and Multivessel Coronary Disease: Insights From the TUXEDO-2 Trial
- DOI
- 10.1097/crd.0000000000001220
- Published
- 2026-03-20
- Container
- Cardiology in Review
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/crd.0000000000001220,
title = {Ticagrelor Versus Prasugrel in Diabetes and Multivessel Coronary Disease: Insights From the TUXEDO-2 Trial},
author = {Siddharth Pravin Agrawal and Anjaneyulu Dunde and Pankti Maniyar and Jaisingh Rajput and Maharshi Raval and Darshil Maheta and Hritvik Jain and William H. Frishman and Wilbert S. Aronow},
year = {2026},
journal = {Cardiology in Review},
doi = {10.1097/crd.0000000000001220},
url = {https://doi.org/10.1097/crd.0000000000001220}
}RIS
TY - JOUR TI - Ticagrelor Versus Prasugrel in Diabetes and Multivessel Coronary Disease: Insights From the TUXEDO-2 Trial AU - Siddharth Pravin Agrawal AU - Anjaneyulu Dunde AU - Pankti Maniyar AU - Jaisingh Rajput AU - Maharshi Raval AU - Darshil Maheta AU - Hritvik Jain AU - William H. Frishman AU - Wilbert S. Aronow PY - 2026 JO - Cardiology in Review DO - 10.1097/crd.0000000000001220 UR - https://doi.org/10.1097/crd.0000000000001220 ER -
APA
Agrawal, S. P., Dunde, A., Maniyar, P., Rajput, J., Raval, M., Maheta, D., Jain, H., Frishman, W. H., & Aronow, W. S. (2026). Ticagrelor Versus Prasugrel in Diabetes and Multivessel Coronary Disease: Insights From the TUXEDO-2 Trial. Cardiology in Review. https://doi.org/10.1097/crd.0000000000001220
Source records
- crossref · retrieved 2026-09-26T10:41:21.093Z